4-aminopyridine has been researched along with fingolimod hydrochloride in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Havla, J; Hohlfeld, R; Kümpfel, T | 1 |
Fox, EJ | 1 |
Buttmann, M; Weise, G | 1 |
Ais-Larisgoitia, A; de Lorenzo-Pinto, A; Rodríguez-González, CG | 1 |
Katz, KD; King, AM; Menke, NB; Pizon, AF | 1 |
Raja Rajeswari, K; Suneetha, A | 1 |
Banzi, R; Bertele', V; Garattini, S; Gerardi, C; Rossi, S | 1 |
5 review(s) available for 4-aminopyridine and fingolimod hydrochloride
Article | Year |
---|---|
Emerging oral agents for multiple sclerosis.
Topics: 4-Aminopyridine; Cladribine; Clinical Trials as Topic; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Quinolones; Sphingosine | 2010 |
[New disease-modifying and symptomatic therapies for multiple sclerosis].
Topics: 4-Aminopyridine; Cannabinoids; Cooperative Behavior; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interdisciplinary Communication; Multiple Sclerosis; Propylene Glycols; Sphingosine | 2012 |
[Emerging therapies for multiple sclerosis].
Topics: 4-Aminopyridine; Administration, Oral; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Cladribine; Clinical Trials as Topic; Crotonates; Daclizumab; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Middle Aged; Multicenter Studies as Topic; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Rituximab; Sphingosine; Toluidines; Young Adult | 2013 |
4-aminopyridine toxicity: a case report and review of the literature.
Topics: 4-Aminopyridine; Adult; Benzodiazepines; Drug Overdose; Fingolimod Hydrochloride; Humans; Male; Multiple Sclerosis; Paroxetine; Propylene Glycols; Sphingosine | 2012 |
Preapproval and postapproval evidence on drugs for multiple sclerosis.
Topics: 4-Aminopyridine; Alemtuzumab; Clinical Trials as Topic; Crotonates; Daclizumab; Dimethyl Fumarate; Drug Development; European Union; Fingolimod Hydrochloride; Humans; Hydroxybutyrates; Immunosuppressive Agents; Interferon-beta; Multiple Sclerosis; Natalizumab; Nitriles; Polyethylene Glycols; Recurrence; Toluidines; Treatment Outcome | 2018 |
2 other study(ies) available for 4-aminopyridine and fingolimod hydrochloride
Article | Year |
---|---|
[Progress of therapy in patients with multiple sclerosis].
Topics: 4-Aminopyridine; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Brain; Cladribine; Clinical Trials as Topic; Fingolimod Hydrochloride; Magnetic Resonance Imaging; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Propylene Glycols; Rituximab; Sphingosine | 2010 |
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Topics: 4-Aminopyridine; Animals; Chromatography, Liquid; Fingolimod Hydrochloride; Perfusion; Plasma; Prednisone; Rats; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2016 |